Immunocytochemistry reveals RANKL expression of myeloma cells.
Sezer
Orhan
O
Heider
Ulrike
U
Jakob
Christian
C
Zavrski
Ivana
I
Eucker
Jan
J
Possinger
Kurt
K
Sers
Christine
C
Krenn
Veit
V
D001854:Bone Marrow Cells / Q000737:chemistry / Q000473:pathology; D002352:Carrier Proteins / Q000032:analysis*; D005434:Flow Cytometry; D006801:Humans; D007150:Immunohistochemistry; D008562:Membrane Glycoproteins / Q000032:analysis*; D009101:Multiple Myeloma / Q000737:chemistry* / Q000150:complications / Q000473:pathology; D009363:Neoplasm Proteins / Q000032:analysis; D010014:Osteolysis / Q000209:etiology; D010950:Plasma Cells / Q000737:chemistry / Q000473:pathology; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B
D002352:Carrier Proteins; D008562:Membrane Glycoproteins; D009363:Neoplasm Proteins; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; C505686:TNFRSF11A protein, human; C505688:TNFSF11 protein, human